buy cialis

Archive for July, 2010

Reimportation Issue Returns

Thursday, July 29th, 2010

Attempting to prevent drug reimportation, the National Association of Chain Drug Stores (NACDS) wrote a letter to Congress pointing out its safety concerns. Have you written your own letters? “NACDS strongly supports policies to help make prescription drugs more affordable.  However, we do not believe consumer safety can be ensured in ...

Can YouTube and Social Media Drive Safer Medical Device Use Among All Patients?

Tuesday, July 27th, 2010

We came across a remarkable study on the number of children injured by medical devices such as contact lenses and others and shared it in our daily newsletter today.  Reported to be the first study of its kind, the research put forth some scary numbers. It also reminded me of ...

Finding Lapses In the Last Mile

Monday, July 26th, 2010

While drug manufacturers have refined their packaging and management of temperature-sensitive shipments, a physicians' survey, and a recent first hand study of wholesaler and hospital practices, point to major quality lapses in the "last mile" of distribution. Physicians perceive cold chain breaks as commonplace, according to a Harris Interactive survey announced ...

Tackle Labeling Errors, One Product at a Time

Friday, July 23rd, 2010

FDA's meeting last month on developing packaging, labeling, and naming guidance to reduce medication errors focused largely labeling, no doubt because many errors occur when users are identifying products and reading instructions. FDA pulled together a diverse group of healthcare professionals who provided valuable input on the challenges, so please ...

Potentially Harmful Stolen Products Found in Pharmacies

Friday, July 16th, 2010

It was probably only a matter of time. Pharmaceutical products reported stolen in August 2009 have surfaced in pharmacies. Today FDA is warning patients "that certain Advair Diskus inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot ...

CAPS Study Zeroes in on Patient Safety

Friday, July 2nd, 2010

In a decades-old debate, the United States Pharmacopeia (USP) is expected to take action that could prevent manufacturers from printing U.S. Food and Drug Administration-required and approved dosage and other identifying information on the caps of injectable drugs. This information serves as a final warning and safety checkpoint before a ...